华邦健康涨2.04%，成交额1.26亿元，主力资金净流入297.89万元

Group 1 - The core viewpoint of the news is that Huabang Health has shown a positive stock performance with a 4.60% increase year-to-date and a significant rise in net profit for the first nine months of 2025 [1][2]. - As of January 13, Huabang Health's stock price reached 5.00 CNY per share, with a market capitalization of 9.9 billion CNY and a trading volume of 1.26 billion CNY [1]. - The company reported a revenue of 9.086 billion CNY for the first nine months of 2025, reflecting a year-on-year growth of 1.98%, while the net profit attributable to shareholders increased by 35.37% to 612 million CNY [2]. Group 2 - Huabang Health's main business segments include agricultural chemicals (58.03% of revenue), pharmaceuticals (27.61%), tourism services (9.00%), and medical services (3.24%) [1]. - The company has distributed a total of 4.909 billion CNY in dividends since its A-share listing, with 1.265 billion CNY distributed over the past three years [3]. - As of September 30, 2025, the number of shareholders decreased by 1.97% to 72,400, while the average number of circulating shares per person increased by 2.01% to 25,997 shares [2][3].